Maternal haloperidol therapy associated with dyskinesia in a newborn.
Collins
Kristine O
KO
Department of Pharmacy, Saint Francis Hospital and Medical Center, 114 Woodland Street, Hartford, CT 06105, USA. kcollins@stfranciscare.org
Comer
Joyce B
JB
D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002998:Clonazepam / Q000627:therapeutic use; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D006220:Haloperidol / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D011618:Psychotic Disorders / Q000188:drug therapy
D000927:Anticonvulsants; D014150:Antipsychotic Agents; D002998:Clonazepam; D006220:Haloperidol